BB
BMY icon

Bell Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bell Bank’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Buy
5,182
+68
+1% +$3.9K 0.01% 168
2026
Q1 		$310K Buy
5,114
+868
+20% +$50.6K 0.01% 152
2025
Q4 		$229K Sell
4,246
-15,021
-78% -$723K 0.01% 178
2025
Q3 		$869K Sell
19,267
-834
-4% -$39K 0.04% 114
2025
Q2 		$930K Hold
20,101
– – 0.04% 106
2025
Q1 		$1.23M Sell
20,101
-110
-0.5% -$6.41K 0.07% 86
2024
Q4 		$1.14M Sell
20,211
-8,909
-31% -$498K 0.09% 91
2024
Q3 		$1.51M Buy
29,120
+258
+0.9% +$12.1K 0.18% 72
2024
Q2 		$1.2M Buy
28,862
+2,334
+9% +$104K 0.1% 83
2024
Q1 		$1.44M Buy
26,528
+1,958
+8% +$99.7K 0.12% 76
2023
Q4 		$1.26M Buy
24,570
+985
+4% +$51.7K 0.12% 84
2023
Q3 		$1.37M Buy
23,585
+1,167
+5% +$71.5K 0.15% 78
2023
Q2 		$1.43M Buy
22,418
+2,827
+14% +$190K 0.15% 81
2023
Q1 		$1.36M Buy
19,591
+54
+0.3% +$3.81K 0.14% 85
2022
Q4 		$1.41M Sell
19,537
-294
-1% -$22.2K 0.16% 80
2022
Q3 		$1.41M Sell
19,831
-1,100
-5% -$79.8K 0.18% 72
2022
Q2 		$1.61M Buy
20,931
+1,519
+8% +$116K 0.19% 74
2022
Q1 		$1.42M Hold
19,412
– – 0.16% 81
2021
Q4 		$1.21M Hold
19,412
– – 0.14% 89
2021
Q3 		$1.15M Hold
19,412
– – 0.14% 87
2021
Q2 		$1.3M Hold
19,412
– – 0.17% 79
2021
Q1 		$1.23M Sell
19,412
-400
-2% -$24.9K 0.18% 76
2020
Q4 		$1.23M Buy
19,812
+400
+2% +$24.6K 0.19% 76
2020
Q3 		$1.17M Hold
19,412
– – 0.21% 67
2020
Q2 		$1.14M Hold
19,412
– – 0.21% 63
2020
Q1 		$1.08M Hold
19,412
– – 0.24% 52
2019
Q4 		$1.25M Buy
19,412
+2,961
+18% +$170K 0.23% 54
2019
Q3 		$834K Hold
16,451
– – 0.16% 74
2019
Q2 		$746K Sell
16,451
-149
-0.9% -$6.94K 0.17% 74
2019
Q1 		$792K Sell
16,600
-708
-4% -$35.3K 0.21% 67
2018
Q4 		$900K Buy
17,308
+705
+4% +$37.9K 0.28% 54
2018
Q3 		$1.03M Sell
16,603
-15,000
-47% -$890K 0.32% 56
2018
Q2 		$1.75M Buy
31,603
+676
+2% +$36.5K 0.54% 43
2018
Q1 		$1.96M Hold
30,927
– – 0.62% 41
2017
Q4 		$1.9M Sell
30,927
-55
-0.2% -$3.44K 0.53% 43
2017
Q3 		$1.98M Sell
30,982
-14
-0% -$817 0.57% 43
2017
Q2 		$1.73M Sell
30,996
-40,513
-57% -$2.2M 0.61% 45
2017
Q1 		$3.89M Buy
71,509
+2,064
+3% +$113K 1.45% 11
2016
Q4 		$4.06M Sell
69,445
-23,675
-25% -$1.29M 1.58% 10
2016
Q3 		$5.02M Buy
93,120
+62,535
+204% +$4.02M 3.16% 4
2016
Q2 		$2.25M Hold
30,585
– – 1.29% 31
2016
Q1 		$1.95M Sell
30,585
-73
-0.2% -$4.6K 1.27% 37
2015
Q4 		$2.11M Sell
30,658
-3,142
-9% -$208K 1.51% 26
2015
Q3 		$2M Sell
33,800
-30,700
-48% -$1.95M 1.59% 14
2015
Q2 		$4.06M Buy
64,500
+33,800
+110% +$2.23M 3.01% 2
2015
Q1 		$1.81M Sell
30,700
-56
-0.2% -$3.51K 1.27% 12
2014
Q4 		$1.82M Hold
30,756
– – 1.25% 13
2014
Q3 		$1.57M Buy
30,756
+45
+0.1% +$2.25K 1.13% 12
2014
Q2 		$1.49M Buy
30,711
+206
+0.7% +$10.2K 1.05% 15
2014
Q1 		$1.58M Buy
30,505
+30
+0.1% +$1.6K 1.06% 14
2013
Q4 		$1.62M Sell
30,475
-60
-0.2% -$3.06K 0.84% 23
2013
Q3 		$1.41M Hold
30,535
– – 0.49% 82
2013
Q2 		$1.36M Buy
+30,535
New +$1.33M 0.48% 87

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Bell Bank's BMY Position: Q2 2026 in Review

Bell Bank increased its Bristol-Myers Squibb (BMY) stake by 1.3% in Q2 2026, buying an estimated $3.9K and bringing the position to 5,182 shares worth $299K. The position accounts for 0.01% of the portfolio, ranked #168.

Bell Bank first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.02M in Q3 2016. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Bell Bank held 5,182 shares of Bristol-Myers Squibb worth $299K as of Q2 2026.
  • Bell Bank bought 68 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.9K.
  • Bristol-Myers Squibb made up 0.01% of Bell Bank's portfolio in Q2 2026, its #168 holding.
  • Bell Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Bell Bank's Bristol-Myers Squibb position peaked at $5.02M in Q3 2016.
  • 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bell Bank's 13F filing for Q2 2026, filed 16 Jul 2026.